These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 776354

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Valproate-associated coagulopathies in children during short-term treatment.
    Köse G, Arhan E, Unal B, Ozaydin E, Guven A, Sayli TR.
    J Child Neurol; 2009 Dec; 24(12):1493-8. PubMed ID: 19482838
    [Abstract] [Full Text] [Related]

  • 24. [Clinical observation of valproate sodium-induced nocturnal enuresis].
    Yokoyama A, Saito Y, Maegaki Y, Ohno K.
    No To Hattatsu; 2007 May; 39(3):227-8. PubMed ID: 17515140
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Valproate-induced bleeding: report of two cases and review of literature.
    Kumar S.
    Indian Pediatr; 2005 Aug; 42(8):833-4. PubMed ID: 16141489
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Generalized onycholysis associated with sodium valproate therapy.
    Grech V, Vella C.
    Eur Neurol; 1999 Jul; 42(1):64-5. PubMed ID: 10523137
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Hyponatremia due to sodium valproate.
    Branten AJ, Wetzels JF, Weber AM, Koene RA.
    Ann Neurol; 1998 Feb; 43(2):265-7. PubMed ID: 9485070
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [A severe disabled case of incomplete Fanconi syndrome after discontinuation of carnitine supplementation during valproate sodium therapy].
    Ono H.
    No To Hattatsu; 2007 May; 39(3):226-7. PubMed ID: 17515139
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Pseudo valproate-induced hypofibrinogenemia.
    Breningstall GN, Cich JA.
    Pediatr Neurol; 1996 May; 14(4):345. PubMed ID: 8962595
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.